Pages that link to "Q37123584"
Jump to navigation
Jump to search
The following pages link to Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein (Q37123584):
Displaying 50 items.
- Computational Refinement and Validation Protocol for Proteins with Large Variable Regions Applied to Model HIV Env Spike in CD4 and 17b Bound State (Q27303608) (← links)
- Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer (Q27680496) (← links)
- Progress in HIV-1 vaccine development. (Q27693849) (← links)
- Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes (Q28271300) (← links)
- A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies (Q28299280) (← links)
- Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein (Q29306052) (← links)
- Stabilized HIV-1 envelope glycoprotein trimers for vaccine use. (Q30490942) (← links)
- Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein (Q33711154) (← links)
- HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies (Q33753573) (← links)
- The immune space: a concept and template for rationalizing vaccine development (Q34399762) (← links)
- Cholesterol-dependent membrane fusion induced by the gp41 membrane-proximal external region-transmembrane domain connection suggests a mechanism for broad HIV-1 neutralization. (Q34594591) (← links)
- Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure (Q34831341) (← links)
- A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene (Q35110976) (← links)
- Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer (Q35217426) (← links)
- Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties (Q35540033) (← links)
- Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer (Q35596474) (← links)
- The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region (Q35860914) (← links)
- Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research (Q35861256) (← links)
- A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS (Q35925858) (← links)
- Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs (Q36267348) (← links)
- Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer. (Q36409575) (← links)
- Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody (Q36736610) (← links)
- Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers (Q37123501) (← links)
- Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation (Q37318042) (← links)
- Native-like Env trimers as a platform for HIV-1 vaccine design (Q37633417) (← links)
- Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein. (Q37649155) (← links)
- Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers (Q37695592) (← links)
- Molecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer (Q38290294) (← links)
- Insights into the trimeric HIV-1 envelope glycoprotein structure (Q38323609) (← links)
- Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens (Q38581943) (← links)
- HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies (Q38665463) (← links)
- Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes. (Q38708708) (← links)
- Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan. (Q38753943) (← links)
- Recognition of HIV-inactivating peptide triazoles by the recombinant soluble Env trimer, BG505 SOSIP.664. (Q38774504) (← links)
- Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits (Q38989507) (← links)
- The HIV-1 envelope glycoprotein structure: nailing down a moving target (Q39108789) (← links)
- HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike (Q39365785) (← links)
- Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers (Q39602726) (← links)
- Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer (Q40061438) (← links)
- Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable to membrane-bound BG505. (Q40130744) (← links)
- Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin. (Q40174150) (← links)
- Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region (Q40251478) (← links)
- Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors (Q40399853) (← links)
- Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers (Q41447893) (← links)
- cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate (Q46067893) (← links)
- Truncating the Gp41 Cytoplasmic Tail of SIV Decreases Sensitivity to Neutralizing Antibodies without Increasing Envelope Content of Virions (Q47398548) (← links)
- Advances in HIV-1 Vaccine Development. (Q52609661) (← links)
- Comparison of Uncleaved and Mature Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimers. (Q52721542) (← links)
- Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies (Q57091049) (← links)
- Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions (Q60917642) (← links)